WSTAM
ARNA

Wilbanks Smith & Thomas Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-25
Closed -$1K – 1436
2018
Q3 		$1K Buy
+25
New +$1.01K ﹤0.01% 1581

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's ARNA Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2018, closing a stake of 25 shares — an estimated $1K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in ARNA in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 177 funds tracked by Wall St. Rank hold ARNA as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 25 Arena Pharmaceuticals Inc shares in Q4 2018, an estimated $1K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Arena Pharmaceuticals Inc position peaked at $1K in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.